Wealthspring Capital’s EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant EQHA.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-77,840
Closed -$771K 432
2022
Q3
$771K Hold
77,840
0.15% 224
2022
Q2
$766K Sell
77,840
-14,250
-15% -$141K 0.14% 237
2022
Q1
$908K Hold
92,090
0.18% 205
2021
Q4
$904K Hold
92,090
0.19% 191
2021
Q3
$921K Sell
92,090
-1,210
-1% -$12K 0.22% 159
2021
Q2
$930K Buy
+93,300
New +$933K 0.23% 142

Wealthspring Capital's EQHA.U Position: Q4 2022 in Review

Wealthspring Capital sold out of EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (EQHA.U) in Q4 2022, closing a stake of 77,840 shares — an estimated $771K sold.

Wealthspring Capital first reported a position in EQHA.U in Q2 2021 and held it in 6 quarters. The position peaked at $930K in Q2 2021. 0 funds tracked by Wall St. Rank hold EQHA.U as of Q4 2022.

  • Wealthspring Capital reported no remaining EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position as of Q4 2022 after selling out during the quarter.
  • Wealthspring Capital sold 77,840 EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant shares in Q4 2022, an estimated $771K.
  • Wealthspring Capital first reported a position in EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q2 2021 and held it in 6 quarters.
  • Wealthspring Capital's EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position peaked at $930K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant as of Q4 2022.

Based on Wealthspring Capital's 13F filing for Q4 2022, filed 8 Feb 2023.